Aurora Cannabis (ACB) revenue breakdown

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $276M

By segment, Cannabis is the largest at 84% of fiscal 2025 revenue, growing 28% a year over 1 years.

By region, Canada is the largest at 45% of fiscal 2026 revenue; Australia grew fastest, 277% a year over 2 years.

Revenue by segment

Fiscal years, as Aurora Cannabis reports them in its 10-K filings; fiscal 2025 total $343M.

Segments20242025Share
Cannabis$225M$289M 84%
Plant propagation production facilities$45M$54M 16%

Revenue by region

Fiscal years, as Aurora Cannabis reports them in its 10-K filings; fiscal 2026 total $321M.

Regions201920202021202420252026Share
Canada————$152M$144M 45%
Europe————$83M$132M 41%
Australia———$3M$51M$39M 12%
New Zealand————$2M$6M 2%
Canada$230M$253M$211M$226M—— —
EU———$41M—— —
European Union$12M$15M$30M——— —
Other$3M$1M$4M$76,000—— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ACB.
Open ACB in Investingly

Questions

Where does Aurora Cannabis make its money?

In fiscal 2025, by segment: Cannabis $289M, Plant propagation production facilities $54M.

From Aurora Cannabis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.